TECHNOLOGY

Adjuvance is dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing. We are commercializing synthetic methods of producing the world’s leading novel vaccine adjuvants.

PRODUCTS & PIPELINE

SAPONEX is Adjuvance’s synthetic version of QS-21. Our lead compound, TiterQuil-1055, is a novel analog of QS-21 that is a superior adjuvant, with its significantly improved safety, efficacy and manufacturing characteristics.

TEAM

We have a team of industry veterans that combines their diverse developmental and commercial experience within the pharmaceutical and healthcare industries. Our team possesses deep knowledge and a wide network of industry relationships.